Regulacje i polityka gospodarcza · 30/12/2005

NIH to Grant Exclusive License for Ocular Therapeutic Agent Delivery Devices and Methods to Lux Biosciences

The National Institutes of Health is considering granting an exclusive worldwide license to Lux Biosciences to practice certain inventions related to ocular therapeutic agent delivery devices and methods, with the potential application in treating dry eye and Sjögren's Syndrome.